As Peptides Go Mainstream, Experts Say Oversight Matters
Peptides Enter the Mainstream: Why Expert Oversight Is No Longer Optional By the B2B Pulse Editorial Team When peptides were the domain of elite biohackers and longevity clinics, the conversation was niche. Today? The landscape has flipped. Peptide therapies are moving from fringe to front-and-center across telehealth platforms, direct-to-consumer wellness brands, and mainstream medical practices. … Read more